Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
antiviral drug |
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
gptkb:J05AF03
|
| gptkbp:CASNumber |
gptkb:7481-89-2
|
| gptkbp:discoveredBy |
Dr. Jerome Horwitz
|
| gptkbp:drugClass |
protease inhibitor
|
| gptkbp:eliminationHalfLife |
1.5 hours
|
| gptkbp:excretion |
gptkb:kidney
|
| gptkbp:hasMolecularFormula |
C9H13N3O3
|
| gptkbp:hasSMILES |
C1=CN(C(=O)NC1=O)[C@H]2O[C@@H](CO)[C@@H](O)C2
|
| gptkbp:hasUNII |
G70B4ETF1Z
|
| https://www.w3.org/2000/01/rdf-schema#label |
dideoxycytidine
|
| gptkbp:IUPACName |
4-amino-1-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2(1H)-one
|
| gptkbp:marketedAs |
Hivid
|
| gptkbp:meltingPoint |
208-210°C
|
| gptkbp:metabolism |
liver
|
| gptkbp:PubChem_CID |
gptkb:DB00943
CHEMBL1425 62329 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
pancreatitis
peripheral neuropathy |
| gptkbp:synonym |
gptkb:zalcitabine
|
| gptkbp:usedFor |
HIV infection
|
| gptkbp:withdrawn |
gptkb:United_States
|
| gptkbp:bfsParent |
gptkb:zalcitabine
|
| gptkbp:bfsLayer |
6
|